EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Glycated haemoglobin, HOMA2‐B , C‐peptide to glucose ratio and type 2 diabetes clusters as predictors for therapy failure in individuals with type 2 diabetes without insulin therapy: A registry analysis

Faisal Aziz iD, Christoph Sternad, Caren Sourij, Lisa Knoll, Harald Kojzar, Anna Schranz, Alexandra Bürger, Harald Sourij iD, Felix Aberer iD

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Faisal Aziz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sanofi-Aventis Deutschland, Sanofi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Some people with type 2 diabetes mellitus (T2D) and declining β‐cell function do require insulin over time. Various laboratory parameters, indices of glucose metabolism or phenotypes of T2D (clusters) have been suggested, which might predict future therapy failure (TF), indicating the need for insulin therapy initiation. This analysis evaluated glycated haemoglobin (HbA1c), homeostatic model assessment (HOMA)2‐B, C‐peptide to glucose ratio (CGR) and diabetes clusters as predictive parameters for the occurrence of glycaemic TF in individuals diagnosed with T2D without previous insulin therapy. Materials and Methods In total, 159 individuals with T2D [41% female, median age 50 (IQR: 53‐69) years, diabetes duration 9 (5‐15) years], without insulin therapy were prospectively evaluated for the occurrence of a composite primary endpoint, including HbA1c increasing or remaining >8.0% (64 mmol/mol) 3 months after baseline on non‐insulin glucose‐lowering agents, insulin initiation or hospital admissions because of acute hyperglycaemic events. Diabetes clusters were formed according to previously described characteristics. Only severe autoimmune diabetes clusters were excluded because of a small amount of glutamate decarboxylase antibody‐positive participants. The other clusters were distributed as mild age‐related diabetes 33%; severe insulin‐deficient diabetes 31%; mild obesity‐related diabetes 20%; and severe insulin‐resistant diabetes 15%.

Results

During a median observation of 57 months, higher tertiles of HbA1c at baseline, HOMA2‐B, as well as a lower CGR were significantly predictive for the occurrence of the primary endpoint. The probability of meeting the primary endpoint was the highest for mild obesity‐related diabetes [hazard ratio 3.28 (95% confidence interval 1.75‐6.2)], followed by severe insulin‐deficient diabetes [hazard ratio 2.03 (95% confidence interval 1.1‐3.7)], mild age‐related diabetes and the lowest for severe insulin‐resistant diabetes. The best performance to predict TF with an area under the curve (AUC) of 0.77 was HbA1c at baseline, followed by HOMA2‐B (AUC 0.69) and CGR (AUC 0.64).

Conclusion

HbA1c, indices of insulin secretion capacity (HOMA2‐B and CGR) and T2D clusters might be applicable tools to guide practitioners in the decision of whether insulin is required in people already diagnosed with T2D. These findings need to be validated in prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Insulin ResistanceFemaleHumansMaleMiddle AgedBlood GlucoseC-PeptideGlucoseGlycated HemoglobinInsulinInsulin, Regular, HumanObesityProspective StudiesRegistriesAged

Stichwörter der Autor:innen

glycaemic controlinsulin therapyreal-world evidencetype 2 diabetes

Substanzen

Blood GlucoseC-PeptideGlucoseGlycated HemoglobinInsulinInsulin, Regular, Human

Autor:innen und Institutionen

  • Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.
  • Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Division of Cardiology, Medical University of Graz, Graz, Austria.

ORCID-Profile: Faisal Aziz, Harald Sourij, Felix Aberer

Förderung

  • Sanofi-Aventis Deutschland
  • Sanofi

Zitieren

APA

Aziz, F., Sternad, C., Sourij, C., Knoll, L., Kojzar, H., Schranz, A., Bürger, A., Sourij, H., & Aberer, F. (2024). Glycated haemoglobin, HOMA2‐B , C‐peptide to glucose ratio and type 2 diabetes clusters as predictors for therapy failure in individuals with type 2 diabetes without insulin therapy: A registry analysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15409

Vancouver

Aziz F, Sternad C, Sourij C, Knoll L, Kojzar H, Schranz A, et al. Glycated haemoglobin, HOMA2‐B , C‐peptide to glucose ratio and type 2 diabetes clusters as predictors for therapy failure in individuals with type 2 diabetes without insulin therapy: A registry analysis. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15409

BibTeX
@article{Aziz2024,
  author = {Aziz, Faisal and Sternad, Christoph and Sourij, Caren and Knoll, Lisa and Kojzar, Harald and Schranz, Anna and Bürger, Alexandra and Sourij, Harald and Aberer, Felix},
  title = {Glycated haemoglobin, HOMA2‐B , C‐peptide to glucose ratio and type 2 diabetes clusters as predictors for therapy failure in individuals with type 2 diabetes without insulin therapy: A registry analysis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15409}
}
Kostenlos starten →